Vertebral Bone Mineral Measures and Psychological Wellbeing Among Individuals with Modic Changes by Briggs, Andrew M. et al.
Open Access
Full open access to this and 
thousands of other papers at 
http://www.la-press.com.
Clinical Medicine Insights: Case Reports 2012:5 35–41
doi: 10.4137/CCRep.S9209
This article is available from http://www.la-press.com.
© the author(s), publisher and licensee Libertas Academica Ltd.
This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
ORiginAL ReSeARCh
Clinical Medicine insights: Case Reports 2012:5  35
Clinical Medicine insights: Case Reports
Vertebral Bone Mineral Measures and psychological  
Wellbeing Among Individuals with Modic changes
Andrew M. Briggs1,2, Peter B. O’Sullivan1, Deryck Foulner4 and John D. Wark2,3 
1School of Physiotherapy and Curtin health innovation Research institute, Curtin University, Australia. 2Department of 
Medicine, University of Melbourne, Royal Melbourne hospital, Australia. 3Bone and Mineral Service, Royal Melbourne 
hospital, Australia. 4Department of Radiology, Sir Charles gairdner hospital, Australia.  
Corresponding author email: a.briggs@curtin.edu.au
Abstract:
Purpose: This case-control pilot study examined whether vertebral bone mineral measures were associated with the presence of chronic 
low back pain (CLBP) and Modic changes (MCs), and to compare psychological wellbeing and inflammation among individuals with 
CLBP and MCs, compared to individuals with no history of low back pain and without MCs.
Methods: Eleven individuals with MRI-defined MCs in the lumbar spine and CLBP (cases) and 10 individuals with no history of CLBP 
or MCs (controls) responded to standard questionnaires regarding pain characteristics and psychological health. Bone mineral density 
(BMD) was measured with postero-anterior and lateral-projection dual energy X-ray absorptiometry (DXA) to estimate areal BMD 
(aBMD) and apparent volumetric BMD (ap.vBMD). High sensitivity serum C-reactive protein (hsCRP) was measured as an index of 
inflammation.
Results: While there was no difference between the groups in measures of depression, anxiety and stress, cases reported significantly 
greater pain catastrophizing attitudes (P , 0.01). hsCRP concentrations did not differ between groups (P = 0.54). Among the 7 cases 
where MCs were identified between L3–4, significantly higher mean aBMD was observed at the affected vertebral level, compared to 
the adjacent, unaffected, cephalad level (P = 0.01–0.04), but not when ap.vBMD was calculated (P = 0.36).
Conclusions: Vertebral BMD is not reduced among individuals with CLBP and MCs compared to a control group, although pain cata-
strophizing attitudes are increased among individuals with CLBP and MCs.
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36  Clinical Medicine insights: Case Reports 2012:5
Introduction
Increased  attention  is  being  directed  towards  the 
relationship between chronic low back pain (CLBP) 
and  vertebral  structural  changes  characterised  by 
bone marrow lesions adjacent to the vertebral end-
plate,  known  as  vertebral  endplate  signal  (Modic) 
changes (MCs). These are MRI-detected abnormali-
ties  in    vertebral  subchondral  bone  extending  from 
the    vertebral  endplate  involving  hypervasculariza-
tion (type 1), replacement of vertebral haematopoetic 
  elements with fat (type 2), and bone sclerosis (type 3). 
MCs, which are strongly associated with degenerative 
intervertebral disc disease,1 represent a specific sub-
group of people with back pain, as they are closely 
associated  with  the  experience  of  low  back  pain.2 
This is in contrast to the finding of degenerative disc 
  disease in the absence of MCs which are poorly asso-
ciated with the self-report of low back pain.3
Although  the  exact  aetiology  of  MCs  remains 
uncertain,  two  pathways  linked  to  intervertebral 
disc degeneration have been proposed in the litera-
ture:  biomechanical,  due  to  abnormal  mechanical 
stresses transferred through the vertebral body; and 
biochemical,  expressed  through  pro-inflammatory 
mediators within the intervertebral disc which become 
particularly significant in situations of disc hernia-
tion.4,5  The  sequelae  via  both  pathways  may  have 
important implications for bone health,6 specifically 
bone mineral density (BMD), although this issue has 
not been studied in detail. While intervertebral disc 
degeneration  has  been  associated  previously  with 
changes  in  the  distribution  of  intra-vertebral  bone 
mass7  and  therefore  is  likely  to  have  implications 
for vertebral bone strength, this has not been linked 
explicitly  with  MCs.  Similarly,  while  mechanisms 
of inflammation-mediated bone loss are well recog-
nised, an association with MCs has not been studied, 
despite recent data highlighting increased concentra-
tions of high sensitivity C-reactive protein (hsCRP) in 
patients with type 1 MCs.8 Furthermore, the personal 
impact of CLBP per se on health-related behaviours 
and wellbeing, may also have negative implications 
for bone health.6
While a number of factors might account for an 
association between BMD and CLBP, the behavioural 
sequelae  of  CLBP  such  as  activity  avoidance  and 
poor psychological wellbeing, leading to increased 
depression, anxiety and stress, are likely to exert a 
significant  influence  on  bone  health.  In  particular, 
depression has been linked to reduced BMD through 
cortisol  dynamics.9  Pain  catastrophizing  attitudes, 
common among individuals who experience chronic 
musculoskeletal  pain,  have  been  linked  to  passive 
coping behaviours and depression, and increase the 
risk of poor outcomes from CLBP,10 which may have 
implications for bone health.6 In the context of MCs, 
the  association  between  CLBP  and  BMD  may  be 
more  pronounced  and  therefore  have  implications 
for surgical interventions commonly undertaken for 
these disorders, such as discectomy, arthrodesis, and 
total disc replacement.11–13 For example, the combina-
tion of inflammation associated with type 1 lesions 
and the clinically-observed high levels of pain, dis-
ability and poor psychological wellbeing in patients 
with CLBP and MCs may strengthen the relationship 
between CLBP and BMD.6 While some clinical char-
acteristics of individuals with CLBP and MCs have 
been reported previously,3,8 these have not specifically 
addressed  BMD  and  psychological  wellbeing,  nor 
the combination of these factors with   inflammation. 
Therefore, the aim of this case-control pilot study was 
to examine whether vertebral bone mineral measures 
were associated with the presence of CLBP and MCs, 
and to compare psychological wellbeing and inflam-
mation among individuals with CLBP and MCs, com-




Community-dwelling  adults  experiencing  CLBP 
(pain duration $ 3 months) in conjunction with the 
  presence of MRI-defined MCs in the lumbar spine 
(cases, n = 11), and individuals with no history of LBP 
in the past year and no evidence of MRI-defined MCs 
in the lumbar spine (controls, n = 12) were recruited 
for  this  study.  Cases  were  recruited  from  primary 
and  secondary  healthcare  facilities,  while  controls 
were recruited from the community. The following 
exclusion criteria were applied during screening to 
eliminate known osteoporosis risk factors and other 
potential confounders of BMD data: aged $55 years, 
BMI , 18 or .28 kg/m2, history of lumbar spine sur-
gery, history of metabolic bone disease, commence-
ment  of  menopause  or  underwent  hysterectomy 
prior to 45 years, history of protracted (.6 months) Modic changes and vertebral BMD
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  exposure to medications known to affect BMD, other 
current condition associated with systemic inflamma-
tion, regular smoking for at least 12 months within the 
last 10 years, excessive alcohol intake (.3 units/day) 
for at least 12 months within the last 10 years. All par-
ticipants provided written informed consent and the 
study was approved by institutional Human Research 
Ethics Committees.
Identification of MCs
All  cases  had  a  previously-acquired  lumbar  MRI 
assessed by a radiologist (DF) to confirm the pres-
ence of MCs, using the Nordic protocol, for which 
reliability has been established.14 All controls had a 
spinal MRI taken at a single imaging provider upon 
entering the study to exclude the presence of MCs. 
Each control MRI was reviewed by the same radi-
ologist using the Nordic protocol. Two controls were 
subsequently  excluded  due  to  the  identification  of 
MCs, such that the total number of controls included 
in the study was n = 10.
Questionnaire data
All  participants  responded  to  the    catastophizing 
subscale  of  the  Coping  Strategies  Question-
naire    (CSQ-CAT)  to  measure  pain  catastrophizing 
  attitudes15 while depression, anxiety and stress were 
measured with the 21-item Depression Anxiety Stress 
Scale (DASS21).16 The CSQ-CAT consists of 6 items 
rated on a 7-point scale and the internal consistency 
of the subscale is reported to be high (α = 0.85).17 
The  DASS-21  has  three  sub-scales  (depression, 
stress and anxiety) each consisting of seven items 
measured on a 4-point scale. The internal consistency 
(α = 0.92–0.95) and reliability (r = 0.65–0.78) of the 
DASS-21 have been established previously.18 Cases 
also responded to questions about LBP-related pain 
intensity  in  the  last  month  using  a  numeric  rating 
scale (NRS),19 and CLBP-related disability using the 
Oswestry Disability Index (ODI). The ODI contains 
10 questions, each with six ordinal responses.   Internal 
consistency of the ODI in adults is reported to range 
from α = 0.71–0.87.20
Bone densitometry
Areal BMD (g/cm2) of the lumbar was acquired with 
a Hologic Discovery A densitometer (Hologic Inc, 
Bedford, MA) in standard postero-anterior (PA) and 
lateral projections using the high definition scanning 
mode. Scans were analysed using Hologic software 
version 12.6.1 to derive BMD at each vertebral level 
L1–L4 in the PA projection and L2–L4 in the lateral 
projection.  Total  spine  BMD  was  calculated  auto-
matically as the mean BMD of the included levels 
from  each  projection.  Apparent  volumetric  BMD 
(ap.vBMD; g/cm3) was derived from the lateral scan 
data using the Hologic width-adjustment feature.
Inflammation
Serum  high  sensitivity  C-reactive  protein  (hsCRP) 
was  measured  24  hours  after  the  cessation  of  any 
analgesic or anti-inflammatory medications and with-
holding of alcohol, consistent with a previous study.8 
HsCRP concentration was measured using a   Siemens 
Healthcare  Diagnostics  reagent  run  on  a  BNII 
  Nephelometer  (Siemens  Healthcare    Diagnostics, 
Deerfield, IL, USA). The assay had a measurement 
range of 0.175–1100 mg/L.
Data analysis
Questionnaire and other data were compared between 
groups using independent t-tests for normally distrib-
uted data and Mann-Whitney U tests for data which 
were  not  normally  distributed.  Among  cases  with 
MCs at levels L3–L4, bone mineral measures were 
compared between the affected vertebral level and 
the immediately adjacent, unaffected cephalad level 
(either L3 or L2) using paired t-tests (data were nor-
mally distributed). The one case which had a Modic 
change  identified  at  L2  was  excluded  from  this 
  within-subject analysis since comparative BMD data 
acquired from lateral-projection DXA cannot be mea-
sured accurately at L1. To examine any difference in 
total spine BMD between cases and controls, which 
might  identify  any  systemic  spinal  bone  deficits, 
a one-way ANCOVA was performed, adjusting for 
age, height and mass (data were normally distributed). 
Data were analysed using SPSS Statistics 17.0.
Results
Among  the  11  cases,  MCs  were  identified  at 
21   vertebral endplates (Table 1). Descriptive charac-
teristics of the cohort and questionnaire data are sum-
marised in Table 2. There was no difference in hsCRP 
concentrations between the groups. While no differ-
ences in DASS21 scores were observed between the Briggs et al
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Table 1. Frequency (%) of Modic change (MC) types 1–3 
identified among the cases (N = 11).
Vertebral level  
endplate
Mc1 Mc2 Mc3 Total
L2 1 (100) 1 (100)
L3 1 (100) 1 (100)
L4 1 (16.7) 4 (66.7) 1 (16.7) 6 (100)
L5 2 (22.2) 7 (77.8) 9 (100)
S1 2 (50.0) 2 (50.0) 4 (100)
Total 7 (33.3) 13 (61.9) 1 (4.8) 21 (100)
Table 2. Descriptive and clinical characteristics of the groups. 
Descriptor case control Mean difference  
(95% cI)
Mann-Whitney   
U test P-value
n [frequency of male (M) and female (F)] 5 M; 6 F 4 M; 6 F – –
Age [years] 44.4 (6.0) 41.1 (8.3) 3.4 (-3.4–10.1) –
height [cm] 175.1 (9.9) 172.6 (6.7) 2.5 (-5.2–10.2) –
Mass [kg] 78.4 (16.1) 75.9 (15.4) 2.5 (-11.9–16.9) –
Lifetime history of LBP [years] 12.6 (11.9) – – –
Usual intensity of pain in last month,  
median (iQR) [possible range 0–10]
6 (2) – – –
ODi [%] 37.1 (13.5) – – –
CSQ-CAT [possible range 0–24] 11.2 (6.1) 2.7 (3.3) 8.5 (3.9–13.0)* –
DASS21—depression [possible range 0–42]^ 4.6 (4.3) 2.4 (3.1) 2.1 (-1.3–5.6) 0.19
DASS21—anxiety [possible range 0–42]^ 3.2 (4.8) 1.6 (2.1) 1.7 (-1.7–5.1) 0.62
DASS21—stress [possible range 0–42] 9.8 (7.5) 7.8 (6.4) 2.0 (-4.3–8.4) –
hsCRP [mg/L]^ 2.2 (2.9) 1.1 (1.1) 1.1 (-1.1–3.2) 0.54
notes: *Significant difference (P , 0.05). Data are expressed as the mean (SD) with the corresponding mean difference and 95% confidence interval 
(95% Ci), unless indicated otherwise. Where data were not normally distributed (indicated with ^), the results of the non-parametric test are included.
groups, the cases reported significantly greater pain 
catastrophizing attitudes.
Vertebral  bone  mineral  measured  we  compared 
between  the  affected  and  adjacent,  unaffected, 
cephalad vertebral level among cases (Table 3). Of the 
7 cases where MCs were identified between vertebral 
levels L3–L4, a significantly-higher mean BMD was 
observed at the affected level compared to the adjacent, 
unaffected cephalad level when acquired in the PA 
(paired difference (95% CI): 0.08 (0.002, 0.15) g/cm2) 
and lateral (0.12 (0.04, 0.20) g/cm2) projections, but 
not when a width-adjustment correction was applied 
(0.08 (-0.12, 0.28) g/cm3).
No significant difference was observed between 
cases and controls for adjusted mean (standard error) 
total lumbar spine BMD acquired in the PA [1.09 (0.03) 
and 1.05 (0.03) g/cm2, respectively; adjusted mean 
difference (95% CI): 0.04 (-0.05, 0.12) g/cm2] and 
  lateral [0.80 (0.02) and 0.75 (0.02) g/cm2,   respectively; 
adjusted mean difference (95% CI): 0.05 (-0.03, 0.12)   
g/cm2] projections, nor when a vertebral width adjust-
ment was applied [0.22 (0.01) and 0.21 (0.01) g/cm3,   
respectively;  adjusted  mean  difference  (95%  CI): 
0.003 (-0.02, 0.02) g/cm3].
Discussion
Vertebral BMD was measured in both PA and lat-
eral  projections  in  this  study.  Lateral-projection 
DXA  has  several  advantages  over  PA-projection. 
First,  it  enables  measurement  of  predominantly 
  metabolically-active trabecular bone in the vertebral 
body without the overriding influence of the cortical-
rich posterior elements of the vertebral body. Second, 
lateral projection-DXA is less affected by degenera-
tive  spinal  structural  changes  and  aortic  calcifica-
tion, which can artificially inflate the vertebral BMD 
measures. Third, an apparent volumetric measure of 
BMD can be derived from lateral-projection scans. 
The  apparent  volumetric  density  measure  is  more 
closely related to true volumetric density than areal 
BMD measures and has greater diagnostic sensitivity 
for bone fragility.21 Areal BMD measured in PA and 
lateral-projections  at  vertebral  levels  where  MCs 
were present was significantly higher compared to the 
adjacent, unaffected cephalad vertebral level. While 
previous data point to a segmental peak in areal BMD 
at L3 followed by a slight decline at L4,22 our data Modic changes and vertebral BMD
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of higher areal BMD at affected levels (usually L4) 
do not support this finding. This may be related to 
increased degenerative spinal conditions associated 
with MCs present at L4,1 and the observed positive 
association  between  areal  BMD  and  intervertebral 
disc degeneration.23 Further, the absence of any dif-
ference between the groups in the concentration of 
hsCRP and depression scores would likely render the 
influence  of  any  inflammation-mediated  bone  loss 
and depression-mediated bone loss, respectively, to 
be negligible. While Rannou et al8 identified differ-
ences in hsCRP between individuals with type 1 and 
type 2 MCs; we are unable to verify this finding in 
our data due to the low sample size of type 1 cases. 
Nonetheless, our data support their finding of no dif-
ference in serum hsCRP concentrations between indi-
viduals with type 2 MCs and controls.
Our finding of no significant difference in ap.vBMD 
between affected and unaffected lumbar vertebrae is 
consistent with recent volumetric BMD data derived 
from computed tomography (CT).24 Further, in con-
trast to areal BMD data reported by Singer et al,22 CT-
derived segmental volumetric BMD is lowest at L3, 
over the range of T1–L5,25 which supports our data. 
The absence of any difference in ap. vBMD between 
the  affected  and  unaffected  vertebrae  suggests  that 
local MCs do not negatively influence bone density. 
  However, given this sample size we are unable to com-
ment regarding the association between vertebral BMD 
and the type of Modic change. This may be an important 
area for future research. The association between MCs 
and bone quality remains uncertain, although this rep-
resents an important area of research given the role of 
bone quality in determining bone strength, independent 
of BMD. While MCs have been associated with bone 
tissue changes measured histologically, little research 
has  been  conducted  to  elucidate  their  influence  on 
bone micro-architecture, for example measured using 
micro-CT. Furthermore, given that MCs are usually 
localised to the subchondral bone adjacent to the ver-
tebral endplate, measurement of whole vertebral body 
BMD by DXA may mask any subregional changes in 
vertebral BMD.21 Measurement of subregional BMD 
profiles  among  individuals  with  MCs  may  be  war-
ranted, particularly in light of recent findings which 
substantiate the use of lateral-projection DXA in this 
context and point to improved diagnostic sensitivity of 
this approach for vertebral fragility.21
Individuals with MCs reported greater pain cata-
strophizing attitudes, consistent with data comparing 
individuals with and without CLBP, including those 
with inflammatory-mediated CLBP,26,27 yet other psy-
chological characteristics (depression, stress, anxiety) 
were not different between the groups, supporting the 
notion that not all CLBP experiences are linked to 
poor psychological states. Mean values for the DASS 
subscales suggest both cases and controls fall within 
the normal ranges for depression, anxiety and stress.28 
Catastrophizing  and  depression  are  considered  co-
existent  yet  independent  predictors  poor  outcomes 
for CLBP. Our data are consistent with a recent study 
indicating individuals with CLBP may demonstrate 
one of either factors,10 nonetheless, the authors high-
lighted that the additive effect of both catastrophzing 
and depression has a significantly greater influence on 
poor outcomes compared to presence of either factor 
in isolation. It may be that a combination of depression 
and catastrophizing is needed before BMD is nega-
tively influenced in the context of CLBP and MCs. 
While the influence of depression on BMD has been 
established previously,9 the influence of catastrophz-
ing should be examined in a larger study.
This study was initiated as a pilot and therefore 
the sample size represents a limitation to the inter-
pretation of the data presented. A larger study should 
now be undertaken to verify the findings in this pilot 
project.  Nonetheless,  novel  and  clinically  relevant 
data are reported which may provide a framework 
for  larger  studies.  Future  studies  should  examine 
the association between different types of MCs and 
BMD and, as well as the association with bone micro-
  architecture, and the association between MCs and 
psychological wellbeing.
Table  3.  Vertebral  bone  mineral  measures  of  affected 
levels  and  adjacent,  cephalad  unaffected  levels  among 
cases.
projection for BMD measure Level Mean (sD)
Postero-anterior (PA) (g/cm2) Affected 1.14 (0.12)
Unaffected 1.06 (0.07)
Lateral (g/cm2) Affected 0.84 (0.15)
Unaffected 0.73 (0.11)
Width-adjusted lateral (g/cm3) Affected 0.28 (0.19)
Unaffected 0.20 (0.03)Briggs et al
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